ENTX Butterfly Strategy
ENTX (Entera Bio Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
ENTX (Entera Bio Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $63.5M, a beta of 1.55 versus the broader market, a 52-week range of 0.91-3.22, average daily share volume of 174K, a public-listing history dating back to 2018, approximately 18 full-time employees. These structural characteristics shape how ENTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.55 indicates ENTX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a butterfly on ENTX?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current ENTX snapshot
As of May 15, 2026, spot at $1.25, ATM IV 23.50%, IV rank 1.22%, expected move 6.74%. The butterfly on ENTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on ENTX specifically: ENTX IV at 23.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a ENTX butterfly, with a market-implied 1-standard-deviation move of approximately 6.74% (roughly $0.08 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ENTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ENTX should anchor to the underlying notional of $1.25 per share and to the trader's directional view on ENTX stock.
ENTX butterfly setup
The ENTX butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ENTX near $1.25, the first option leg uses a $1.19 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ENTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ENTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.19 | N/A |
| Sell 2 | Call | $1.25 | N/A |
| Buy 1 | Call | $1.31 | N/A |
ENTX butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
ENTX butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on ENTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on ENTX
Butterflies on ENTX are pinning bets - traders use them when they expect ENTX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
ENTX thesis for this butterfly
The market-implied 1-standard-deviation range for ENTX extends from approximately $1.17 on the downside to $1.33 on the upside. A ENTX long call butterfly is a pinning play: it pays maximum at the middle strike if ENTX settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current ENTX IV rank near 1.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ENTX at 23.50%. As a Healthcare name, ENTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ENTX-specific events.
ENTX butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ENTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ENTX alongside the broader basket even when ENTX-specific fundamentals are unchanged. Always rebuild the position from current ENTX chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on ENTX?
- A butterfly on ENTX is the butterfly strategy applied to ENTX (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With ENTX stock trading near $1.25, the strikes shown on this page are snapped to the nearest listed ENTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ENTX butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the ENTX butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 23.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ENTX butterfly?
- The breakeven for the ENTX butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ENTX market-implied 1-standard-deviation expected move is approximately 6.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on ENTX?
- Butterflies on ENTX are pinning bets - traders use them when they expect ENTX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current ENTX implied volatility affect this butterfly?
- ENTX ATM IV is at 23.50% with IV rank near 1.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.